Mark J Ahn Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark J Ahn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark J Ahn. Mark J Ahn is Director in ABEONA THERAPEUTICS INC. ($AKC) and President and CEO in Talon Therapeutics, Inc. ($EMLR).
Latest Insider Trading Transactions of Mark J Ahn
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 15 2016 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Option Exercise | A | 4.45 | 150,000 | 667,500 | 150,000 | |
Nov 09 2016 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Option Exercise | M | 2.31 | 150,000 | 346,500 | 0 | |
Nov 09 2016 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Buy | M | 2.31 | 150,000 | 346,500 | 493,182 | 343.2 K to 493.2 K (+43.71 %) |
Feb 16 2016 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Option Exercise | A | 2.31 | 150,000 | 346,500 | 150,000 | |
Aug 03 2015 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Buy | P | 5.50 | 18,182 | 100,001 | 343,182 | 325 K to 343.2 K (+5.59 %) |
May 13 2015 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Option Exercise | A | 7.34 | 100,000 | 734,000 | 115,320 | |
May 13 2015 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Grant | A | 7.34 | 300,000 | 2,202,000 | 325,000 | 25 K to 325 K (+1,200.00 %) |
Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 1.68 | 194,568 | 327,653 | 194,568 | |
Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | D | 0.34 | 194,568 | 65,569 | 0 | |
Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 1.68 | 79,658 | 134,144 | 79,658 | |
Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | D | 0.34 | 79,658 | 26,845 | 0 | |
Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 0.83 | 184,555 | 153,734 | 184,555 | |
Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | D | 0.17 | 184,555 | 30,821 | 0 | |
Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 0.83 | 329,016 | 274,070 | 329,016 | |
Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | D | 0.17 | 329,016 | 54,946 | 0 | |
Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Grant | A | 0.00 | 74,887 | 0 | 602,631 | 527.7 K to 602.6 K (+14.19 %) |
Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Grant | A | 0.00 | 325,000 | 0 | 527,744 | 202.7 K to 527.7 K (+160.30 %) |
Jul 07 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Grant | A | 0.00 | 85,000 | 0 | 287,774 | 202.8 K to 287.8 K (+41.92 %) |
May 18 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 9.07 | 5,500 | 49,885 | 202,744 | 197.2 K to 202.7 K (+2.79 %) |
May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | M | 1.57 | 5,859 | 9,199 | 0 | |
May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | M | 1.57 | 5,859 | 9,199 | 0 | |
May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | M | 0.17 | 164,508 | 27,473 | 329,016 | |
May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | M | 1.57 | 5,859 | 9,199 | 33,336 | 27.5 K to 33.3 K (+21.32 %) |
May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | M | 1.57 | 5,859 | 9,199 | 197,244 | 191.4 K to 197.2 K (+3.06 %) |
May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | M | 0.17 | 164,508 | 27,473 | 191,385 | 26.9 K to 191.4 K (+612.08 %) |
May 11 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 26,877 | 31.9 K to 26.9 K (-15.69 %) |
Mar 27 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 10.63 | 1,000 | 10,630 | 31,877 | 30.9 K to 31.9 K (+3.24 %) |
Nov 15 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 4.75 | 155,179 | 737,100 | 155,179 | |
Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | P | 5.80 | 1,089 | 6,316 | 1,089 | |
Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | P | 5.80 | 1,089 | 6,316 | 1,089 | |
Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 4.59 | 5,446 | 24,997 | 27,477 | 22 K to 27.5 K (+24.72 %) |
Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Gift | G | 0.00 | 500 | 0 | 22,031 | 21.5 K to 22 K (+2.32 %) |
Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Gift | G | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 4.59 | 5,446 | 24,997 | 30,877 | 25.4 K to 30.9 K (+21.41 %) |
Oct 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Gift | G | 0.00 | 3,100 | 0 | 25,431 | 28.5 K to 25.4 K (-10.87 %) |
Jul 18 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 1.63 | 2,000 | 3,260 | 28,531 | 26.5 K to 28.5 K (+7.54 %) |
Apr 29 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | P | 1.57 | 5,859 | 9,199 | 5,859 | |
Apr 29 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | P | 1.57 | 5,859 | 9,199 | 5,859 | |
Apr 29 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 1.28 | 19,531 | 25,000 | 21,531 | 2 K to 21.5 K (+976.55 %) |
Apr 29 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 1.28 | 19,531 | 25,000 | 26,531 | 7 K to 26.5 K (+279.01 %) |
Apr 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 1.33 | 126,501 | 168,246 | 126,501 | |
Jan 27 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Grant | A | 0.00 | 5,000 | 0 | 7,000 | 2 K to 7 K (+250.00 %) |
Jan 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 2.45 | 2,000 | 4,900 | 2,000 | 0 to 2 K |
Jan 21 2005 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Buy | P | 2.50 | 2,000 | 5,000 | 2,000 | 0 to 2 K |
Page: 1